Clinical Trial

DuraDerm® for the Reduction of Pin Track Infection

Study Description

DuraDerm® for the Reduction of Pin Track Infection

The purpose of the study is to investigate additional clinical uses for DuraDermAR. DuraDermAR is a FDA approved, 510k, medical device, but has not been approved for use on patients with pin track sites as a way to lower the infection rate and is investigational for this purpose. The approved uses include wound care and post-operative care. About 20 subjects will take part in this study.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - DuraDerm

DuraDerm® is a 510K FDA cleared medical device indicated for providing a covering over minor wounds and scrapes that are clean and dry. The microbicidal liquid solution consists of organic polymers . The unique formulation eradicates any organisms (bacteria, fungi, viruses) it comes in contact with. This is a result of the solvent's activity against an infinite number of organisms After eradication is complete, the solvent then transitions into a clear, elastomeric, non-odorous film for coverin ...read more on ClinicalTrials.org

Additional Information

Official Study Title

An Evaluation of the Use of DuraDerm® for the Reduction of Pin Track Infection in Research Participants Receiving External Fixation Following Deformity Correction and Traumatic Provisional Fixation

Clinical Trial ID

NCT03756506

ParticipAid ID

bo2Aza